• Vetiranary Medicine
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

FDA warns pet owners, veterinarians of NSAID toxicity from use of topical flurbiprofen

April 21, 2015

Three cats have died, others sickened after owners applied cream or lotion containing the anti-inflammatory drug.

The U.S. Food and Drug Administration (FDA) has issued a warning that even very small amounts of topical pain medication containing the nonsteroidal anti-inflammatory drug (NSAID) flurbiprofen can cause illness and death in pets. The agency is encouraging veterinarians who have patients who show signs of NSAID toxicity to ask their clients if anyone in the household has used topical medications containing flurbiprofen.

The FDA says it has received reports of cats in two households that became ill or died after their owners used topical medications containing flurbiprofen. "The pet owners had applied the cream or lotion to their own neck or feet, and not directly to the pet, and it is not known exactly how the cats became exposed to the medication," the FDA states in a release.

In one household, two cats developed kidney failure and recovered with veterinary care, according to the FDA. Two cats in a second household developed signs that included reluctance to eat, lethargy, vomiting, melena, anemia and dilute urine. Both died despite care. The FDA says a third cat in the household also died after the owner stopped using the medication. Necropsies on all three cats found evidence of NSAID toxicity.

Veterinarians should encourage clients to take precautions with flurbiprofen medications, the FDA says. It recommends that pet owners do the following to prevent or reduce pet exposure:

> Store all medications safely out of the reach of pets.

> Safely discard or clean any cloth or applicator that may retain medication and avoid leaving any residues of the medication on clothing, carpeting or furniture.

Advertisement

> Consult your healthcare provider on whether it is appropriate to cover the treated area.

> If you are using topical medications containing flurbiprofen and your pet becomes exposed, bathe or clean your pet as thoroughly as possible and consult a veterinarian.

> If your pet shows signs such as lethargy, lack of appetite, vomiting or other illness, seek veterinary care for your pet and be sure to provide the details of the exposure.

The FDA has not received reports of dogs or other pets becoming sick in relation to the use of topical pain medications containing flurbiprofen; however, these animals may also be vulnerable to NSAID toxicity after being exposed to these medications.

Pet owners and veterinarians can report any adverse events to the FDA at fda.gov.

Related Content:

Breaking News
Veterinarian kills 2 police officers in Mississippi
Veterinarian kills 2 police officers in Mississippi
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
FDA conditionally approves Panoquell-CA1 for acute onset of canine pancreatitis
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals
Veterinarians reflect on Queen Elizabeth’s legacy and love of animals

Advertisement

Latest News

Managing wounds in pet patients

Spectrum of care: protocols to support pet owners’ budgets

How to support women while still running a successful business

The Vets expands to Raleigh, NC

View More Latest News
Advertisement